News
RLFTF
0.352
NaN%
--
MindMaze sharpens U.S. neurotherapeutics push after NeuroX–Relief merger and 2025 report
TipRanks · 10h ago
MindMaze Therapeutics FY25 net loss totals CHF 9.9 million; revenue CHF 0.6 million
PUBT · 10h ago
Weekly Report: what happened at RLFTF last week (0406-0410)?
Weekly Report · 2d ago
Weekly Report: what happened at RLFTF last week (0330-0403)?
Weekly Report · 04/06 10:08
MindMaze, Vibra Report Real-World Stroke Rehab Gains From High-Dose Digital Therapy
TipRanks · 03/31 05:35
MindMaze RWE study shows high-dose neurorehab boosts stroke recovery vs standard care
Reuters · 03/31 05:04
Weekly Report: what happened at RLFTF last week (0323-0327)?
Weekly Report · 03/30 10:08
Weekly Report: what happened at RLFTF last week (0316-0320)?
Weekly Report · 03/23 10:04
MindMaze Wins Baader Bank Coverage With Buy Rating, Boosting Market Visibility
TipRanks · 03/19 06:35
Baader Bank initiates coverage on MindMaze Therapeutics with buy rating and CHF 1.8 target price
Reuters · 03/19 05:32
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
Barchart · 03/18 21:35
Weekly Report: what happened at RLFTF last week (0309-0313)?
Weekly Report · 03/16 10:04
MindMaze Names New CEO to Drive U.S. Expansion and Scale AI Neurotherapies
TipRanks · 03/12 06:34
MindMaze Therapeutics names Zach Henderson CEO and appoints Alexandre Capet Chief Operating and Strategy Officer
Reuters · 03/12 05:47
Weekly Report: what happened at RLFTF last week (0302-0306)?
Weekly Report · 03/09 10:05
MindMaze Therapeutics Holding SA Publishes March 2026 Investor Presentation
Reuters · 03/03 07:11
MindMaze Therapeutics board members Van Beek and Stünkel step down
Reuters · 03/03 06:51
MindMaze maps post-listing push to scale digital neurotherapies in U.S. and Europe
TipRanks · 03/03 06:34
Weekly Report: what happened at RLFTF last week (0223-0227)?
Weekly Report · 03/02 10:04
Weekly Report: what happened at RLFTF last week (0216-0220)?
Weekly Report · 02/23 10:04
More
Webull provides a variety of real-time RLFTF stock news. You can receive the latest news about Relief Hldg through multiple platforms. This information may help you make smarter investment decisions.
About RLFTF
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.